Page 822 - 先天性心脏病的导管术：从婴幼儿期到成人期

804 先天性心脏病的导管术：从婴幼儿期到成人期

2014;7(9):1060-9. https://doi.org/10.1016/j.jcin.2014.04.013.

[9] Cevallos PC, Armstrong AK, Glatz AC, et al. Radiation dose benchmarks in pediatric
cardiac catheterization: a prospective multi-center C3PO-QI study. Catheter Cardiovasc
Interv. 2017;90(2):269-80. https://doi.org/10.1002/ccd.26911.
[10] Bergersen L, Gauvreau K, Foerster SR, et al. Catheterization for Congenital Heart Dis-

ease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv. 2011;4(9):1037-
46. https://doi.org/10.1016/j.jcin.2011.05.021.
[11] Jayaram N, Spertus JA, Kennedy KF, et al. Modeling major adverse outcomes of pedi-
atric and adult patients with congenital heart disease undergoing cardiac catheterization:

observations from the NCDR IMPACT Registry (National Cardiovascular Data Registry
Improving Pediatric and Adult Congenital Trial). Circulation. 2017;136(21):2009-19.
https://doi.org/10.1161/CIRCULATIONAHA.117.027714.
[12] Bergersen L, Giroud JM, Jacobs JP, et al. Report from The International Society for No-

menclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation
for congenital and paediatric cardiac disease (Part 2-Nomenclature of complications as-
sociated with interventional cardiology). Cardiol Young. 2011;21(3):260-5. https://doi.
org/10.1017/S1047951110001861.